Bruker Co. Announces Quarterly Dividend of $0.05 (NASDAQ:BRKR)

Bruker Co. (NASDAQ:BRKRGet Free Report) declared a quarterly dividend on Monday, February 24th, Wall Street Journal reports. Stockholders of record on Monday, March 17th will be given a dividend of 0.05 per share by the medical research company on Friday, March 28th. This represents a $0.20 annualized dividend and a dividend yield of 0.39%. The ex-dividend date of this dividend is Monday, March 17th.

Bruker has increased its dividend by an average of 7.7% annually over the last three years. Bruker has a dividend payout ratio of 6.5% meaning its dividend is sufficiently covered by earnings. Equities analysts expect Bruker to earn $3.15 per share next year, which means the company should continue to be able to cover its $0.20 annual dividend with an expected future payout ratio of 6.3%.

Bruker Stock Up 2.1 %

Shares of NASDAQ:BRKR traded up $1.07 during midday trading on Monday, reaching $51.89. 1,519,493 shares of the company were exchanged, compared to its average volume of 1,646,538. The firm has a market cap of $7.87 billion, a PE ratio of 68.28, a P/E/G ratio of 2.16 and a beta of 1.16. The company has a quick ratio of 0.77, a current ratio of 1.60 and a debt-to-equity ratio of 1.15. Bruker has a fifty-two week low of $48.07 and a fifty-two week high of $94.86. The stock has a fifty day simple moving average of $56.73 and a two-hundred day simple moving average of $60.03.

Bruker (NASDAQ:BRKRGet Free Report) last issued its quarterly earnings results on Thursday, February 13th. The medical research company reported $0.76 EPS for the quarter, beating analysts’ consensus estimates of $0.75 by $0.01. Bruker had a return on equity of 21.01% and a net margin of 3.36%. As a group, sell-side analysts forecast that Bruker will post 2.69 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of equities analysts have weighed in on the company. Stifel Nicolaus reduced their price target on Bruker from $70.00 to $57.00 and set a “hold” rating for the company in a research report on Friday, February 14th. Barclays reduced their target price on shares of Bruker from $69.00 to $65.00 and set an “overweight” rating for the company in a report on Monday, February 10th. Citigroup lowered their price target on shares of Bruker from $80.00 to $75.00 and set a “buy” rating on the stock in a research note on Wednesday, November 6th. Wells Fargo & Company reduced their price objective on shares of Bruker from $78.00 to $75.00 and set an “overweight” rating for the company in a research note on Wednesday, November 6th. Finally, TD Cowen dropped their target price on Bruker from $72.00 to $70.00 and set a “hold” rating on the stock in a report on Wednesday, November 6th. Six investment analysts have rated the stock with a hold rating and six have issued a buy rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $70.50.

Read Our Latest Stock Analysis on BRKR

Bruker Company Profile

(Get Free Report)

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.

Read More

Dividend History for Bruker (NASDAQ:BRKR)

Receive News & Ratings for Bruker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bruker and related companies with MarketBeat.com's FREE daily email newsletter.